Chest
Volume 114, Issue 5, Supplement, November 1998, Pages 579S-589S
Antithrombotic Therapy in Atrial Fibrillation
Section snippets
Study Design
During the last decade, many studies assessing the efficacy of antithrombotic therapy for the prevention of stroke in AF have been published7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 (Table 1, Table 2, Table 3, Table 4). Six of the studies were randomized controlled trials comparing oral anticoagulation with control.7,14, 15, 16, 17, 18 The first Atrial Fibrillation, Aspirin, and Anticoagulation Study (AFASAK1), the first Stroke Prevention in Atrial Fibrillation Study (SPAF1), and the
References (73)
- et al.
Prevalence of cardiovascular disease and diabetes in residents of Rochester, Minnesota
Mayo Clin Proc
(1990) - et al.
European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the prevention of stroke
J Neurol Sci
(1996) - et al.
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
J Am Coll Cardiol
(1991) - et al.
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
Lancet
(1996) - et al.
Thyrotoxicosis, atrial fibrillation, and embolism, revisited
Am Heart J
(1989) - et al.
The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation
Am J Cardiol
(1969) - et al.
Cardioversion and defibrillation
Am Heart J
(1980) - et al.
Pulsed doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation
J Am Coll Cardiol
(1989) - et al.
Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5 year study
J Am Coll Cardiol
(1995) - et al.
Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials
Am Heart J
(1995)
Immediate and long-term results of electrical reversion of arrhythmias
Prog Cardiovasc Med
(1966)
Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiography study
J Am Coll Cardiol
(1994)
Thromboembolism following cardioversion of “common” atrial flutter: risk factors and limitations of transesophageal echocardiography
Chest
(1996)
Risk of thromboembolism in chronic atrial flutter
Am J Cardiol
(1997)
Thromboembolism in chronic atrial flutter: is the risk underestimated?
J Am Coll Cardiol
(1997)
Delayed restoration of atrial function after cardioversion of atrial flutter by pacing or electrical cardioversion
Am J Cardiol
(1993)
The prevalence of atrial fibrillation: analysis and implications
Arch Intern Med
(1995)
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Stroke
(1991)
Atrial fibrillation and mortality in an elderly population
Aust N Z J Med
(1989)
Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study)
Am J Cardiol
(1994)
Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials
Arch Intern Med
(1994)
European Atrial Fibrillation Trial: secondary prevention of vascular events in patients with non-rheumatic atrial fibrillation and a recent transient ischaemic attack or minor ischaemic stroke
Lancet
(1993)
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial
Lancet
(1996)
Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study
JAMA
(1998)
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation
Stroke
(1997)
Letter to the Editor
J Neurol Sci
(1997)
Fixed mini-dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation; Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study (the AFASAK2 study)
Arch Intern Med
(1998)
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study
Lancet
(1989)
Stroke Prevention in Atrial Fibrillation Study: final results
Circulation
(1991)
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
N Engl J Med
(1990)
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
N Engl J Med
(1992)
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
Lancet
(1994)
The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from three randomized trials
Arch Intern Med
(1997)
Risk factors for intracranial hemorrhage in outpatients taking warfarin
Ann Intern Med
(1994)
Optimal oral anticoagulant therapy in patients with mechanical heart valves
N Engl J Med
(1995)
Stroke prevention in atrial fibrillation II study [letter]
Lancet
(1994)
Cited by (0)
Copyright © 1998 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.